This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Grarup, N. Articles by Pedersen, O. Search for Related Content PubMed PubMed Citation Articles by Grarup, N. Articles by Pedersen, O. Related Collections Lipid Cardiovascular Endocrinology

The –250G>A Promoter Variant in Hepatic Lipase Associates with Elevated Fasting Serum High-Density Lipoprotein Cholesterol Modulated by Interaction with Physical Activity in a Study of 16,156 Danish Subjects

Steno Diabetes Center (N.G., C.H.A., M.K.A., K.B.-J., T.H., O.P.), 2820 Gentofte, Denmark; Department of Medicine (M.K.A.), University of Helsinki and Helsinki University Central Hospital, FIN-00290 Helsinki, Finland; Department of Biostatistics (A.A.), University of Copenhagen, DK-1017 Copenhagen, Denmark; Departments of General Practice (A.S., T.L.) and Clinical Pharmacology (O.S.), and Faculty of Health Sciences (K.B-J., O.P.), University of Aarhus, DK-8000 Aarhus, Denmark; Research Centre for Prevention and Health (K.B.-J., T.J.), Glostrup University Hospital, DK-2600 Glostrup, Denmark; and Department of Endocrinology and Diabetes (O.S.), Aarhus University Hospital, DK 8200 Aarhus, Denmark

Address all correspondence and requests for reprints to: Niels Grarup, Steno Diabetes Center, Niels Steensens Vej 1, NLC2.14, 2820 Gentofte, Denmark. E-mail: ngrp{at}steno.dk.

Context: Hepatic lipase plays a pivotal role in the metabolism of high-density lipoprotein (HDL) and low-density lipoprotein by involvement in reverse cholesterol transport and the formation of atherogenic small dense low-density lipoprotein.

Objectives: The objective was to investigate the impact of variants in LIPC on metabolic traits and type 2 diabetes in a large sample of Danes. Because behavioral factors influence hepatic lipase activity, we furthermore examined possible gene-environment interactions in the population-based Inter99 study.

Design: The LIPC –250G>A (rs2070895) variant was genotyped in the Inter99 study (n = 6070), the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care Denmark screening cohort of individuals with risk factors for undiagnosed type 2 diabetes (n = 8662), and in additional type 2 diabetic patients (n = 1,064) and glucose-tolerant control subjects (n = 360).

Results: In the Inter99 study, the A allele of rs2070895 associated with a 0.057 mmol/liter [95% confidence interval (CI) 0.039–0.075] increase in fasting serum HDL-cholesterol (HDL-c) (P = 8 x 10^–10) supported by association in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care study [0.038 mmol/liter per allele (95% CI 0.024–0.053); P = 2 x 10^–7). The allelic effect on HDL-c was modulated by interaction with self-reported physical activity (P_interaction = 0.002) because vigorous physically active homozygous A-allele carriers had a 0.30 mmol/liter (95% CI 0.22–0.37) increase in HDL-c compared with homozygous G-allele carriers.

Conclusions: We validate the association of LIPC promoter variation with fasting serum HDL-c and present data supporting an interaction with physical activity implying an increased effect on HDL-c in vigorous physically active subjects carrying the –250 A allele. This interaction may have potential implications for public health and disease prevention.